Analysts think AGEN stock price could increase by 152%
Dec 23, 2024, 12:26 PM
35.34%
What does AGEN do
Agenus, a US-based biotechnology company headquartered in Lexington, specializes in immuno-oncology therapies targeting cancer and infectious diseases, employing 389 staff. Its pipeline includes advanced antibodies and various immunotherapy classes.
5 analysts think AGEN stock price will increase by 152.30%. The current median analyst target is $7.14 compared to a current stock price of $2.83. The lowest analysts target is $6.06 and the highest analyst target is $11.55.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
